Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Board approves five-year appointment, subject to shareholder nod through postal ballot
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment
Subscribe To Our Newsletter & Stay Updated
